Daniel Y Bargieri
Overview
Explore the profile of Daniel Y Bargieri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
616
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bargieri D, Williamson K
Cell Host Microbe
. 2019 May;
25(5):631-632.
PMID: 31071289
In recent work, Paton et al. (2019) report that mosquitoes exposed to atovaquone, a known antimalarial, are resistant to infection by the malaria parasite Plasmodium. Their results may be the...
12.
Calit J, Dobrescu I, Gaitan X, Borges M, Ramos M, Eastman R, et al.
Antimicrob Agents Chemother
. 2018 Sep;
62(11).
PMID: 30181368
Malaria remains an important parasitic disease with a large morbidity and mortality burden. transmission-blocking (TB) compounds are essential for achieving malaria elimination efforts. Recent efforts to develop high-throughput screening (HTS)...
13.
Lima M, Melo-Filho C, Cassiano G, Neves B, Alves V, Braga R, et al.
Front Pharmacol
. 2018 Mar;
9:146.
PMID: 29559909
Malaria is a life-threatening infectious disease caused by parasites of the genus , affecting more than 200 million people worldwide every year and leading to about a half million deaths....
14.
Cravo P, Machado R, Leite J, Leda T, Suwanarusk R, Bittencourt N, et al.
Malar J
. 2018 Jan;
17(1):20.
PMID: 29316918
Background: Technical limitations for culturing the human malaria parasite Plasmodium vivax have impaired the discovery of vaccine candidates, challenging the malaria eradication agenda. The immunogenicity of the M2 domain of...
15.
Gimenez A, Lima L, Francoso K, Denapoli P, Panatieri R, Bargieri D, et al.
Front Immunol
. 2017 Oct;
8:1275.
PMID: 29075260
is the most common species that cause malaria outside of the African continent. The development of an efficacious vaccine would contribute greatly to control malaria. Recently, using bacterial and adenoviral...
16.
Bargieri D, Thiberge S, Tay C, Carey A, Rantz A, Hischen F, et al.
Cell Host Microbe
. 2016 Nov;
20(5):618-630.
PMID: 27832590
Surface-associated TRAP (thrombospondin-related anonymous protein) family proteins are conserved across the phylum of apicomplexan parasites. TRAP proteins are thought to play an integral role in parasite motility and cell invasion...
17.
Leite J, Bargieri D, Carvalho B, Albrecht L, Lopes S, Kayano A, et al.
Infect Immun
. 2015 Jul;
83(10):3781-92.
PMID: 26169268
Malaria remains a world-threatening disease largely because of the lack of a long-lasting and fully effective vaccine. MAEBL is a type 1 transmembrane molecule with a chimeric cysteine-rich ectodomain homologous...
18.
Bargieri D, Andenmatten N, Lagal V, Thiberge S, Whitelaw J, Tardieux I, et al.
Nat Commun
. 2013 Oct;
4:2552.
PMID: 24108241
Apicomplexan parasites invade host cells by forming a ring-like junction with the cell surface and actively sliding through the junction inside an intracellular vacuole. Apical membrane antigen 1 is conserved...
19.
Carey A, Menard R, Bargieri D
Methods Mol Biol
. 2012 Sep;
923:371-83.
PMID: 22990792
Sporozoites, the stage of Plasmodium infectious to vertebrates when injected in the skin by a mosquito vector, are highly motile cells. Their unusual form of gliding motility is essential for...
20.
Lacroix C, Giovannini D, Combe A, Bargieri D, Spath S, Panchal D, et al.
Nat Protoc
. 2011 Sep;
6(9):1412-28.
PMID: 21886105
We describe here a highly efficient procedure for conditional mutagenesis in Plasmodium. The procedure uses the site-specific recombination FLP-FRT system of yeast and targets the pre-erythrocytic stages of the rodent...